Director Shareholding
01 Juli 2003 - 4:26PM
UK Regulatory
RNS Number:0203N
Proteome Sciences PLC
01 July 2003
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1 Name of Company
Proteome Sciences plc
2 Name of Director
Dr. Sandra Steiner
3 Please state whether notification indicates that it is in respect of holding of the shareholder named
in 2 above or in respect of a non beneficial interest or in the case of an individual holder if it is
a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial
interest
As 2 Above
4 Name of the registered holder(s) and, if more than one holder, the number of shares held by each of
them (if notified)
N/A
5 Please state whether notification relates to a person(s) connected with the Director named in 2 above
and identify the connected person(s)
As 2 Above
6 Please state the nature of the transaction. For PEP transactions please indicate whether general/
single co PEP and if discretionary/non discretionary
Grant of Options
(24,000 shares under the Approved Scheme)
(326,000 shares under the Unapproved Scheme)
If a director has been granted options by the company please complete the following boxes
17 Date of grant
30 June 2003
18 Period during which or date on which exercisable
The Approved Scheme shares (24,000) 30 June 2006 - 30 June 2013
The Unapproved Scheme shares (326,000) 30 June 2006 - 30 June 2010
19 Total amount paid (if any) for grant of the option
Nil
20 Description of shares or debentures involved: class, number
350,000 Ordinary Shares of 1p each
21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise
125p
22 Total number of shares or debentures over which options held following this notification
350,000 shares
23 Any additional information
24 Name of contact and telephone number for queries
James Malthouse 01932 865065
25 Name and signature of authorised company official responsible for making this notification
James Malthouse 01932 865065
26 Date of Notification
1 July, 2003
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUUUCPMUPWGCG